CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,166,000 | -0.4% | 226,658 | -0.6% | 0.00% | – |
| Q3 2020 | $4,183,000 | +24.6% | 228,070 | +1.7% | 0.00% | – |
| Q2 2020 | $3,358,000 | -2.5% | 224,318 | +3.0% | 0.00% | – |
| Q1 2020 | $3,444,000 | -7.4% | 217,730 | -4.9% | 0.00% | – |
| Q4 2019 | $3,718,000 | +14.6% | 228,966 | +4.9% | 0.00% | – |
| Q3 2019 | $3,243,000 | -7.9% | 218,216 | +2.4% | 0.00% | – |
| Q2 2019 | $3,522,000 | +14.4% | 213,063 | +19.8% | 0.00% | – |
| Q1 2019 | $3,078,000 | +1.5% | 177,898 | +3.6% | 0.00% | – |
| Q4 2018 | $3,032,000 | -2.1% | 171,714 | +0.6% | 0.00% | – |
| Q3 2018 | $3,098,000 | +11.9% | 170,682 | +20.5% | 0.00% | – |
| Q2 2018 | $2,769,000 | +1291.5% | 141,664 | +1150.5% | 0.00% | – |
| Q1 2018 | $199,000 | -86.9% | 11,329 | -91.2% | 0.00% | – |
| Q1 2017 | $1,515,000 | -9.2% | 128,469 | +1.0% | 0.00% | – |
| Q4 2016 | $1,668,000 | -3.2% | 127,213 | +7.0% | 0.00% | – |
| Q3 2016 | $1,724,000 | +25.3% | 118,885 | +3.5% | 0.00% | – |
| Q2 2016 | $1,376,000 | -37.1% | 114,909 | -1.9% | 0.00% | – |
| Q1 2016 | $2,188,000 | +0.7% | 117,138 | +15.9% | 0.00% | – |
| Q4 2015 | $2,172,000 | +43.1% | 101,106 | +12.6% | 0.00% | – |
| Q3 2015 | $1,518,000 | -12.1% | 89,766 | +95.3% | 0.00% | – |
| Q2 2015 | $1,727,000 | – | 45,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|